PATIENTS & FAMILIES
The INTO-HLH Registry is a patient registry for people diagnosed with hemophagocytic lymphohistiocytosis (HLH) in North America.
INTO-HLH is a collaborative effort with Cincinnati Children's Hospital Medical Center (CCHMC), Baylor College of Medicine, the North American Consortium for Histiocytosis (NACHO), and Sobi North America as the industry sponsor.
What is the INTO-HLH Registry?
An electronic database designed to collect information about HLH and its treatments. Information is collected from participants' medical records and routine clinical care.
The Registry aims to advance what is known about HLH. The insights obtained from this Registry will help doctors to better manage HLH in the future.
What are the objectives of the INTO-HLH Registry?
- Understand more about how HLH progresses over time, including its symptoms and impact on patients' quality of life
- Investigate how patients respond to treatments and what are the corresponding outcomes
- Learn more about the long-term complications experienced by patients with HLH and the general well-being of patients and caregivers
What will taking part in the INTO-HLH Registry involve?
- The INTO-HLH Registry will collect data (also called "medical information") from the participants' medical records and their routine clinical care over a period of five years
- This information will include the progression of the condition, its symptoms and treatments, and the outcome of the treatment
- The Registry will also collect information on how HLH impacts patients' daily life and long-term outcomes